Valuation: DIAGNOS Inc.

Market Cap 5.98Cr 4.19Cr 3.72Cr 3.48Cr 3.17Cr 402.98Cr 6.03Cr 42Cr 16Cr 206.01Cr 16Cr 15Cr 661.15Cr P/E 2025
-6.18x
P/E 2026 -6.51x
Enterprise Value 5.92Cr 4.16Cr 3.69Cr 3.45Cr 3.14Cr 399.44Cr 5.98Cr 42Cr 16Cr 204.2Cr 16Cr 15Cr 655.34Cr EV / Sales 2025
293x
EV / Sales 2026 498x
Free-Float
94.52%
Yield 2025 *
-
Yield 2026 -
1 day+1.05%
1 week-2.04%
3 months+77.78%
6 months+74.55%
Current year+28.00%
1 week 0.47
Extreme 0.47
0.5
1 month 0.42
Extreme 0.42
0.53
Current year 0.18
Extreme 0.175
0.53
1 year 0.18
Extreme 0.175
0.53
3 years 0.18
Extreme 0.175
0.57
5 years 0.12
Extreme 0.125
0.59
10 years 0.1
Extreme 0.1
2
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 01/05/2008
Chief Operating Officer - 16/01/2024
Director TitleAgeSince
Director/Board Member - 21/09/2000
Director/Board Member 72 28/09/2020
Chairman 69 30/10/2025
Date Insider Type Main position Quantity % Market Cap. Importance
28/08/26 Buy

Director

1,05,000 0.0872%
21/08/26 Option

Director

-1,00,000 0.0830%
21/08/26 Option

Director

1,00,000 0.0830%
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-2.04%+47.69%-9.43% 4.19Cr
-1.32%-1.27%-22.79%+58.59% 21TCr
-0.84%+0.29%-2.36%+17.44% 19TCr
-0.55%+0.01%+61.11%+497.72% 12TCr
-0.28%+1.52%+45.07%+129.21% 12TCr
-6.31%+12.94%-18.92%-35.05% 12TCr
+1.19%-0.34%-28.50%-40.95% 7.81TCr
+0.72%+0.04%-26.83%-8.41% 5.82TCr
+1.19%+2.32%-33.51% - 4.94TCr
+1.67%+1.02%+15.50%+133.58% 4.48TCr
Average -0.35%+1.49%+3.65%+82.52% 9.96TCr
Weighted average by Cap. -1.02%+1.77%+0.79%+96.29%

Financials

2025 2026
Net sales 1L 72.81T 64.69T 60.38T 55.04T 70L 1L 7L 3L 35.78L 3L 3L 1.15Cr 65.48T 45.93T 40.81T 38.09T 34.72T 44.16L 66.09T 5L 2L 22.57L 2L 2L 72.45L
Net income -42.86L -30.07L -26.72L -24.94L -22.73L -29Cr -43.26L -3.02Cr -1.17Cr -15Cr -1.13Cr -1.1Cr -47Cr -45.55L -31.95L -28.39L -26.5L -24.15L -31Cr -45.98L -3.21Cr -1.24Cr -16Cr -1.2Cr -1.17Cr -50Cr
Net Debt -2L -1L -1L -95.23T -86.8T -1.1Cr -2L -11.52L -4L -56.44L -4L -4L -1.81Cr -5L -4L -3L -3L -3L -3.54Cr -5L -36.97L -14.33L -1.81Cr -13.83L -13.53L -5.81Cr
Logo DIAGNOS Inc.
Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.
Employees
22
Date Price Change Volume
02/26/02 CA$0.4800 +1.05% 1,19,750
01/26/01 CA$0.4750 -1.04% 2,52,810
30/26/30 CA$0.4800 -0.52% 2,09,508
29/26/29 CA$0.4825 +0.52% 3,06,500
28/26/28 CA$0.4800 -2.04% 1,86,040

Annual profits - Rate of surprise